Dengue: actualizaciones en diagnóstico y tratamiento
IKEEP. Neelika Malavige, Laura Talarico, Alfonso Rodriguez-Morales and Bridget Wills . 06/01/21; 333284
  Neelika Malavige, Laura Talarico, Alfonso Rodriguez-Morales and Bridget Wills
Neelika Malavige, Laura Talarico, Alfonso Rodriguez-Morales and Bridget Wills
Contributions Biography
About this activity
Learning Objectives
This webinar was hosted on June 16, 2021, 9:00 - 10:00 EST.

Chair: Neelika Malavige and Laura Talarico.

Unusual Clinical Presentations
Alfonso Rodriguez-Mora

Clinical Management - Innovations and Controversies
Bridget Wills

 
Dengue is one of the most common mosquito-borne viral illnesses worldwide. Dengue causes a wide spectrum of diseases ranging from subclinical disease to severe flu-like symptoms in those infected. Today, severe dengue affects most Asian and Latin American countries and has become a leading cause of hospitalization and death among children and adults in these regions. Similar symptoms and laboratory findings between dengue and coronavirus disease (COVID-19) can pose a diagnostic challenge in dengue-endemic countries. Speakers will discuss the use of diagnostics with a focus on implementation in endemic regions and present innovations and controversies in the clinical management of severe dengue, including the use of novel therapeutics. Speakers will also highlight the challenges of unusual presentations that are now seen in higher frequency including Dengue-induced organ-specific damage unrelated to shock such as liver disease or encephalitis and presentations in the elderly.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies